Last reviewed · How we verify

Vaginal Lactobacillus Dual Probiotic Capsules — Competitive Intelligence Brief

Vaginal Lactobacillus Dual Probiotic Capsules (Vaginal Lactobacillus Dual Probiotic Capsules) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Probiotic. Area: Gynecology.

phase 3 Probiotic Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

Vaginal Lactobacillus Dual Probiotic Capsules (Vaginal Lactobacillus Dual Probiotic Capsules) — Guangdong Longchuangji Pharmaceutical Co., Ltd.. This drug restores the balance of vaginal microbiota by introducing beneficial Lactobacillus strains.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vaginal Lactobacillus Dual Probiotic Capsules TARGET Vaginal Lactobacillus Dual Probiotic Capsules Guangdong Longchuangji Pharmaceutical Co., Ltd. phase 3 Probiotic
Lactobacillus Reuteri Probiotic Lactobacillus Reuteri Probiotic Liaquat National Hospital & Medical College marketed Probiotic
Probiotic (Lactobacillus reuteri Prodentis Probiotic (Lactobacillus reuteri Prodentis Universidad de Colima marketed Probiotic
Lactobacillus Species Lactobacillus Species Vedic Lifesciences Pvt. Ltd. marketed Probiotic
Lactobacillus Rhamnosus Lactobacillus Rhamnosus Chang Gung Memorial Hospital marketed Live biotherapeutic / Probiotic
Lactobacillus casei Lactobacillus casei Hospital Cristo Re marketed Probiotic
Combizym + Bifidobacteri Combizym + Bifidobacteri RenJi Hospital marketed Enzyme and probiotic combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Probiotic class)

  1. BioBalance Corporation · 1 drug in this class
  2. Biocodex · 1 drug in this class
  3. CD Pharma India Pvt. Ltd. · 1 drug in this class
  4. CHU de Quebec-Universite Laval · 1 drug in this class
  5. Chuncheon Sacred Heart Hospital · 1 drug in this class
  6. Dow University of Health Sciences · 1 drug in this class
  7. Federico II University · 1 drug in this class
  8. Fundación Hospital de Pediatría Prof. Dr. Juan P. Garrahan · 1 drug in this class
  9. GWT-TUD GmbH · 1 drug in this class
  10. Aga Khan University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vaginal Lactobacillus Dual Probiotic Capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/vaginal-lactobacillus-dual-probiotic-capsules. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: